26.75 USD
-0.38 (-1.4%)
Last: Feb 11, 2026, 12:38 PM
ChartMill assigns a Buy % Consensus number of 81% to AGIO. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 39.2. This target is 46.53% above the current price.
- AGIO was analyzed by 16 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about AGIO.
- In the previous month the buy percentage consensus was at a similar level.
- AGIO was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-06 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-12-26 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-12-24 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-24 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-26 | Citigroup | Initiate | Buy |
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-21 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-20 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-11-20 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-11-20 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-11-20 | B of A Securities | Maintains | Buy -> Buy |
| 2025-11-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-28 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-07-22 | B of A Securities | Maintains | Buy -> Buy |
| 2025-05-02 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-12-09 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-11-01 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-11-01 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-10-16 | ScotiaBank | Initiate | Sector Outperform |
| 2024-10-10 | Raymond James | Reiterate | Outperform |
| 2024-09-27 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-19 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-06-17 | Cantor Fitzgerald | Reiterate | Overweight |
AGIOS PHARMACEUTICALS INC / AGIO FAQ
What is the price target for AGIO stock?
16 analysts have analysed AGIO and the average price target is 39.2 USD. This implies a price increase of 46.53% is expected in the next year compared to the current price of 26.75.
What is the consensus rating for AGIOS PHARMACEUTICALS INC (AGIO) stock?
The consensus rating for AGIOS PHARMACEUTICALS INC (AGIO) is 81.25 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover AGIOS PHARMACEUTICALS INC (AGIO) stock?
The number of analysts covering AGIOS PHARMACEUTICALS INC (AGIO) is 16.